Advertisement

Topics

JPMorgan belässt GlaxoSmithKline auf 'Neutral' - Ziel 1750 Pence

07:52 EDT 30 Jun 2017 | FinanzNachrichten

Die US-Bank JPMorgan hat die Einstufung für GlaxoSmithKline auf "Neutral" mit einem Kursziel von 1750 Pence belassen. Die Markterwartungen an das inzwischen so wichtige HIV-Geschäft der Briten dür...

Original Article: JPMorgan belässt GlaxoSmithKline auf 'Neutral' - Ziel 1750 Pence

NEXT ARTICLE

More From BioPortfolio on "JPMorgan belässt GlaxoSmithKline auf 'Neutral' - Ziel 1750 Pence"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...